Andere Sprachen 10x Genomics, Inc.

Aktien

A2PPQJ

US88025U1097

TXG

Medizinische Versorgung

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 21.04.2026			% 5 Tage	Veränd. 1. Jan.
22,97 ^USD	-6,59 %		-2,59 %	+40,83 %

19.04.	10x Genomics führt Atera-Plattform ein	CI
31.03.	10x Genomics legt nach Hochstufung durch William Blair zu	MT

Andere Sprachen

19.04.	10x Genomics : Introduces Atera
19.04.	10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
19.04.	10x Genomics Introduces Atera Platform
31.03.	10x Genomics Shares Rise After William Blair Upgrade
25.03.	Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
17.03.	PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
19.02.	10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
13.02.	10x Genomics : Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
12.02.	(TXG) 10x Genomics Expects 2026 Revenue Range $600M-$625M, vs. FactSet Est of $611.6M
12.02.	10x Genomics Q4 Loss Narrows, Revenue Rises; 2026 Guidance Set
12.02.	10x Genomics: Q4 Earnings Snapshot
12.02.	Earnings Flash (TXG) 10x Genomics, Inc. Reports Q4 Revenue $166.0M, vs. FactSet Est of $159.7M
12.02.	10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
12.02.	10X Genomics, Inc. Provides Earnings Guidance for the Full Year 2026
12.02.	10x Genomics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
04.02.	PharosAI and 10x Genomics partner to transform cancer research with AI and spatial biology
04.02.	Pharosai and 10X Genomics Partner to Transform Cancer Research with Ai and Spatial Biology
04.02.	10x Genomics, PharosAI Enter Cancer Research Partnership
04.02.	PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
26.01.	10x Genomics : BioTuring and 10x Genomics Announce Strategic Collaboration to Streamline Single Cell and Spatial Data Analysis
22.01.	10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
12.01.	Cancer Research Institute Launches Transformative Ai-Driven Immuno-Oncology Initiative Powered by 10X Genomics Technology
12.01.	10X Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
12.01.	10X Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
12.01.	10x Genomics Unveils Collaborations in Oncology, Blood-Based Diagnostics